Cardioinhibitory syncope: from pathophysiology to treatment—should we think on cardioneuroablation?

@article{Garcia2020CardioinhibitorySF,
  title={Cardioinhibitory syncope: from pathophysiology to treatment—should we think on cardioneuroablation?},
  author={Alan Garcia and M. Marquez and Emilse F. Fierro and J. J. Baez and Leyla P. Rockbrand and Jorge Gomez-Flores},
  journal={Journal of Interventional Cardiac Electrophysiology},
  year={2020},
  volume={59},
  pages={441-461}
}
Vasovagal syncope (VVS) is the most common type of syncope; the lone cardioinhibitory syncope represents only a small group of patients; however, the “cardioinhibitory component” is highly prevalent in reflex syncope and can be severe enough to produce asystole, lasting for a few seconds followed by a recovery to sinus beats. The environment in which syncope occurs can compromise life, and in-depth knowledge of the disease can prevent deaths and guide the appropriate management. The therapeutic… Expand
1 Citations
Clinical values of creatine kinase and its isoenzymes in children and adolescents with vasovagal syncope.

References

SHOWING 1-10 OF 151 REFERENCES
Ganglionated plexi ablation in right atrium to treat cardioinhibitory neurocardiogenic syncope
What role might cardioneuroablation strategy have in syncope guidelines?
Endocardial Autonomic Denervation of the Left Atrium to Treat Vasovagal Syncope: An Early Experience in Humans
Neurocardiogenic Syncope
International study on syncope of uncertain aetiology 3 (ISSUE 3): pacemaker therapy for patients with asystolic neurally-mediated syncope: rationale and study design.
  • M. Brignole
  • Medicine
  • Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology
  • 2007
...
1
2
3
4
5
...